Target intelligence / Profile preview

Cellular metabolic and reparative pathways

Molecular classification
Other
01

Overview

Cellular metabolic and reparative pathways represent a broad and heterogeneous collection of biochemical processes essential for maintaining cellular life, energy production, and genomic integrity (Alberts et al., Molecular Biology of the Cell, 2014). These pathways include central carbon metabolism, such as glycolysis and the citric acid cycle, as well as various DNA damage response (DDR) mechanisms like base excision repair and homologous recombination (Hanahan & Weinberg, Cell, 2011). While these processes are fundamental to health, they are frequently dysregulated in diseases like cancer, where metabolic reprogramming supports rapid growth, or in liver disease, where metabolic clearance is impaired. In clinical practice, certain agents like Metadoxine are described as enhancing these pathways to accelerate the metabolism of toxins like ethanol (Addolorato et al., Int J Immunopathol Pharmacol, 2003). However, because this term describes a functional category rather than a single protein or receptor, it is not considered a specific therapeutic target; instead, drug discovery efforts focus on individual enzymes or signaling molecules within these pathways, such as PARP for DNA repair or AMPK for metabolism (Lord & Ashworth, Nature, 2012).

Other names
Metabolic pathwaysDNA repair pathwaysCellular repair mechanismsCellular homeostasis
02

Mechanism of action

Drugs associated with these pathways act through diverse mechanisms, including the activation of metabolic sensors like AMPK, the inhibition of DNA repair enzymes like PARP, or the provision of metabolic precursors to enhance detoxification and cellular repair (Lord & Ashworth, Nature, 2012; Addolorato et al., Int J Immunopathol Pharmacol, 2003).

03

Biological functions

MetabolismDNA repairCellular homeostasisEnergy productionDetoxification
04

Disease associations

CancerMetabolic syndromeLiver diseaseAgingNeurodegenerative disease
05

Safety considerations

Systemic metabolic disruptionCytotoxicity in healthy tissuesPotential for secondary malignancies with DNA repair modulation
06

Interacting drugs

Metadoxine

3 more in the full profile.

07

Biomarkers

LactateGlucosegamma-H2AXATP levelsNAD+/NADH ratio

Beyond the preview

Go deeper on Cellular metabolic and reparative pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular metabolic and reparative pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call